BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32668063)

  • 1. Efficacy and infection morbidity of front-line immuno-chemotherapy in follicular lymphoma.
    Djebbari F; Kaji F; Stanton L; Lawrence MM; Collins GP; Eyre TA
    Eur J Haematol; 2020 Nov; 105(5):667-671. PubMed ID: 32668063
    [No Abstract]   [Full Text] [Related]  

  • 2. Progressive multifocal leukoencephalopathy during rituximab maintenance after rituximab and bendamustine treatment for relapsed follicular lymphoma.
    Lucijanic M; Jaksic O
    Ann Hematol; 2020 Sep; 99(9):2191-2192. PubMed ID: 32556456
    [No Abstract]   [Full Text] [Related]  

  • 3. Fatal visceral varicella-zoster infection following rituximab and chemotherapy treatment in a patient with follicular lymphoma.
    Bermúdez A; Marco F; Conde E; Mazo E; Recio M; Zubizarreta A
    Haematologica; 2000 Aug; 85(8):894-5. PubMed ID: 10942955
    [No Abstract]   [Full Text] [Related]  

  • 4. Rituximab-induced serum sickness in a patient with follicular lymphoma.
    Disperati P; Hicks LK; Buckstein R
    Leuk Lymphoma; 2007 Aug; 48(8):1633-5. PubMed ID: 17701597
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term clinical improvement of progressive multifocal leukoencephalopathy associated with prominent inflammatory response and follicular lymphoma.
    Vastagh I; Bereczki D; Várallyay G; Palásti A; Demeter J; Fodor A; Csomor J; Aberle SW; Budka H; Kovacs GG
    Leuk Lymphoma; 2011 Nov; 52(11):2190-2. PubMed ID: 21707304
    [No Abstract]   [Full Text] [Related]  

  • 6. Front-line management of non-Hodgkin lymphoma in Australia. Part 1: follicular lymphoma.
    Trotman J; Cheah CY; Marlton P; Opat S
    Intern Med J; 2019 Apr; 49(4):422-433. PubMed ID: 30230156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults.
    Schaaf M; Reiser M; Borchmann P; Engert A; Skoetz N
    Cochrane Database Syst Rev; 2012 Jan; 1():CD007678. PubMed ID: 22258971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lethal enterovirus myocarditis associated with rituximab and chemotherapy for follicular lymphoma].
    Alonso JJ; Cánovas A; Rubio G
    Med Clin (Barc); 2013 Nov; 141(10):459-60. PubMed ID: 23622890
    [No Abstract]   [Full Text] [Related]  

  • 9. Short duration immunochemotherapy followed by radioimmunotherapy consolidation is effective and well tolerated in relapsed follicular lymphoma: 5-year results from a UK National Cancer Research Institute Lymphoma Group study.
    Illidge TM; McKenzie HS; Mayes S; Bates A; Davies AJ; Pettengell R; Stanton L; Cozens K; Hampson G; Dive C; Zivanovic M; Tipping J; Gallop-Evans E; Radford JA; Johnson PW
    Br J Haematol; 2016 Apr; 173(2):274-82. PubMed ID: 26849853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No reactivation of JCV in bone marrow of follicular lymphoma patients treated front-line with rituximab plus 90y-ibritumomab tiuxetan.
    Focosi D; Macera L; Ciabatti E; Galimberti S; Petrini M; Carella AM; Pistello M; Ceccherini-Nelli L; Maggi F
    Infection; 2014 Dec; 42(6):1065-6. PubMed ID: 25143192
    [No Abstract]   [Full Text] [Related]  

  • 11. Low number of intrafollicular T cells may predict favourable response to rituximab-based immuno-chemotherapy in advanced follicular lymphoma: a secondary analysis of a randomized clinical trial.
    Budau L; Wilhelm C; Moll R; Jäkel J; Hirt C; Dölken G; Maschmeyer G; Neubauer E; Strauch K; Burchert A; Herold M; Neubauer A
    J Cancer Res Clin Oncol; 2019 Aug; 145(8):2149-2156. PubMed ID: 31273513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy and treatment algorithms for follicular lymphoma: a look at all options.
    Steffanoni S; Ghielmini M; Moccia A
    Expert Rev Anticancer Ther; 2015; 15(11):1337-49. PubMed ID: 26414532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. R-CHOP, radioimmunotherapy, and maintenance rituximab in untreated follicular lymphoma (SWOG S0801): a single-arm, phase 2, multicentre study.
    Barr PM; Li H; Burack WR; LeBlanc M; Smith SM; Gopal AK; Floyd JD; Persky DO; Press OW; Fisher RI; Friedberg JW
    Lancet Haematol; 2018 Mar; 5(3):e102-e108. PubMed ID: 29396094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab: a review of its use in chronic lymphocytic leukaemia, low-grade or follicular lymphoma and diffuse large B-cell lymphoma.
    Keating GM
    Drugs; 2010 Jul; 70(11):1445-76. PubMed ID: 20614951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy versus autologous stem-cell transplantation for the treatment of transformed follicular lymphoma in the rituximab era.
    Tam CS; Herschtal A; Dickinson M; George A; Seymour JF
    J Clin Oncol; 2013 Sep; 31(25):3166-7. PubMed ID: 23918946
    [No Abstract]   [Full Text] [Related]  

  • 16. Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance.
    D'Alò F; Malafronte R; Piludu F; Bellesi S; Cuccaro A; Maiolo E; Modoni A; Leccisotti L; Macis G; Mores N; De Stefano V; Hohaus S
    Br J Haematol; 2020 May; 189(4):e140-e144. PubMed ID: 32150646
    [No Abstract]   [Full Text] [Related]  

  • 17. Overview of Southwest Oncology Group Clinical Trials in non-Hodgkin Lymphoma. S0016. A phase III trial of CHOP vs CHOP + rituximab vs CHOP + iodine131-labeled monoclonal anti-B1 antibody (tositumomab) for treatment of newly diagnosed follicular NHL.
    Fisher RI
    Clin Adv Hematol Oncol; 2005 Jul; 3(7):544-6. PubMed ID: 16167036
    [No Abstract]   [Full Text] [Related]  

  • 18. Watch-and-wait policy versus rituximab-combined chemotherapy in Japanese patients with intestinal follicular lymphoma.
    Tari A; Kitadai Y; Mouri R; Takigawa H; Asaoku H; Mihara K; Takata K; Fujihara M; Yoshino T; Koga T; Fujimori S; Tanaka S; Chayama K
    J Gastroenterol Hepatol; 2018 Aug; 33(8):1461-1468. PubMed ID: 29377265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follicular Lymphoma: Redefining Prognosis, Current Treatment Options, and Unmet Needs.
    Welaya K; Casulo C
    Hematol Oncol Clin North Am; 2019 Aug; 33(4):627-638. PubMed ID: 31229159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial Treatment of Early Stage and Low Tumor Burden Follicular Lymphoma.
    Cohen JB; Kahl BS
    Hematol Oncol Clin North Am; 2020 Aug; 34(4):663-672. PubMed ID: 32586572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.